Size and gene content of copy number variations (CNVs)
Regions of homozygosity, which may suggest shared ancestry and an increased risk for autosomal recessive disorders
Uniparental disomy, which can indicate an imprinting disorder
The American College of Medical Genetics, American Academy of Pediatrics, and the American Academy of Neurology recommend chromosomal microarray testing for individuals with one or more of the following:2-4
Developmental delays or intellectual disability
Autism and autism spectrum disorders
Other potential disorders such as seizures and ADHD
Recommended by the American College of Medical Genetics as a first-tier test in lieu of high-resolution karyotyping
Doubles the detection rate of chromosomal disorders compared to high-resolution karyotyping and subtelomere FISH combined
Higher resolution than karyotyping
More comprehensive than karyotyping, which helps prevent unnecessary testing
Microarray results are typically available in 10-12 days, on average, from the time samples are received by Invitae’s lab.
G-banded karyotype results are typically available in 12 days, on average, from the time samples are received by Invitae’s lab.
Invitae technology provides superior clinically focused, genome-wide coverage.
Invitae’s reports include references to assist in patient counseling and tools for evaluating non-copy number related abnormalities, such as regions of homozygosity.
Invitae’s laboratory directors have decades of experience in interpreting microarray results and can assist you in understanding complex results.
Allows clinicians without in-house phlebotomy services to collect samples in-office
Frees patients from making a second trip to an off-site draw station
Provides patients who are unable to give a blood sample a more comfortable alternative
Makes genetic testing more accessible to general practitioners, pediatricians, child neurologists, behavioral pediatricians, and other office-based physicians
Invitae is proud to be in-network for more than 300 million patients, and offer a financial assistance program for patients without coverage.
Request a free specimen collection kit online.
Receive a comprehensive results report
More than 9% of healthy adults have a genetic risk of developing cancer. Cancer screening offers healthy adults an opportunity to understand their DNA, assess heritable cancer risk, and take proactive action if necessary.
80% of children born with genetic disorders have no family history. The American College of Obstetricians and Gynecologists recommends offering carrier screening to all patients of reproductive age.
More than 50% of all early pregnancy losses are due to a fetal chromosomal abnormality. Chromosomal microarray analysis can help identify the cause of recurrent miscarriage.